Ibnsina Pharma (EGX:ISPH)

Market Cap	12.00B +77.6%
Revenue (ttm)	72.83B +50.0%
Net Income	702.99M +94.5%
EPS	0.70 +94.5%
Shares Out	1.01B
PE Ratio	17.06
Forward PE	10.30
Dividend	0.16 (1.41%)
Ex-Dividend Date	Oct 13, 2025

Volume	3,853,559
Average Volume	9,072,020
Open	11.78
Previous Close	11.78
Day's Range	11.25 - 11.98
52-Week Range	6.35 - 13.72
Beta	0.59
RSI	42.86
Earnings Date	Feb 25, 2026

About Ibnsina Pharma

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services, as well as value added services. The company was founded in 2001 and is headquartered in El Obour City, Egypt.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2001
• Employees: 5,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ISPH

Financial Performance

In 2024, Ibnsina Pharma's revenue was 55.84 billion, an increase of 64.49% compared to the previous year's 33.95 billion. Earnings were 497.80 million, an increase of 187.51%.